FDA Inspection 1117609 — Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.
The FDA completed an inspection of Blood Bank Of Delmarva, a Division of New York Blood Center, Inc. on February 11, 2020 in Newark, DE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 11, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Newark, DE (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 9236 | 21 CFR 630.40(b)(1) | Deferred or not eligible |
| 9239 | 21 CFR 630.40(b)(4) | Follow up and counseling |